Demographics | CIS-PD study | Open PRIDE-HD sub-study |
---|---|---|
Total patients | 51 | 17 |
Gender: males | 29 (57%) | 9 (53%) |
Ethnicity: Caucasian | 45 (88%) | 16 (94%) |
Ethnicity: Hispanic | 1 (2%) | 1 (16%) |
Age (mean ± s.d.) | 62 ± 11 | 51 ± 12 |
Years since symptom onset (mean ± s.d.) | 9 ± 5 | NA |
Years since diagnosis onset (mean ± s.d.) | 7 ± 5 | NA |
PD: Hoehn & Yahr (mean ± s.d.) | 2 ± 0.42 | NA |
PD: MDS-UPDRS Part 1 at baseline (mean ± s.d.) | 10 ± 5 | NA |
PD: MDS-UPDRS Part 2 at baseline (mean ± s.d.) | 10 ± 5 | NA |
PD: MDS-UPDRS Part 3 at baseline (mean ± s.d.) | 24 ± 11 | NA |
HD: UHDRS-TMS | NA | 37 ± 14 |
HD: Number of CAG repeats | NA | 44 ± 3 |
HD: Neuroleptic use | NA | 2 (12%) |
HD: UHDRS-Total Functional Capacity | NA | 8 (2) |